Remove 2008 Remove Liabilities Remove Shareholders
article thumbnail

CrowdStrike Stock Is Back Above $300 Per Share. Is It Going Back to Its All-Time High?

The Motley Fool

Moreover, CrowdStrike partners with insurers to help protect its customers from such incidents through cyber risk and cyber liability insurance. Nonetheless, that may only help shareholders up to a point. Apple: if you invested $1,000 when we doubled down in 2008, you’d have $43,047 !*

Bidding 246
article thumbnail

3 Top Dividend ETFs That Could Build Generation-Spanning Wealth

The Motley Fool

While technology stocks have dominated returns since the 2008 financial crisis, surpassing even the red-hot real estate sector, they often experience dramatic price swings and rely heavily on continued advances in artificial intelligence and automation. The fund's largest positions demonstrate its focus on established market leaders.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Billionaires Are Deciding to Sell Shares of This Well-Known Stock

The Motley Fool

Buffett alluded to the threat of a higher capital gains tax rate, which seemed to have faded since earlier this year, and selling Apple does help to clear the deck for Berkshire's tax liability. Susquehanna has also owned Apple stock for a long time, first buying it in the third quarter of 2008. million shares.

article thumbnail

This Stock Turned $10,000 Into $263,690 Since Its 2016 IPO. Here's Why It's Not Too Late to Buy.

The Motley Fool

One stock that has provided stellar returns for its shareholders since its 2016 initial public offering (IPO) is Kinsale Capital (NYSE: KNSL). The specialty insurance company has a strong position in a highly competitive industry and has rewarded shareholders handsomely in the process. For one, these companies enjoy consistent demand.

article thumbnail

Is Kinsale Capital Stock a Buy?

The Motley Fool

Kinsale Capital (NYSE: KNSL) is one such company that has consistently delivered remarkable returns to its shareholders. Robust demand comes from businesses and people wanting to protect themselves from unmitigated disasters, such as hurricanes, tornadoes, flooding, cybersecurity attacks, or product defect liabilities.

Capital 130
article thumbnail

3 Things You Need to Know if You Buy Viking Therapeutics Today

The Motley Fool

Furthermore, it has less than $1 million in noncurrent liabilities, meaning that it has a tremendous amount of leeway to borrow money if necessary. And with a share price that's inflated right now, issuing new equity to raise capital wouldn't even cause much harm to shareholders. So financially, this biotech is rock-solid.

article thumbnail

3 Things You Need to Know If You Buy Summit Therapeutics Stock Today

The Motley Fool

Its current debt liability is $100 million. However, if the company can hold out until after one of its ongoing clinical trials wraps up and reports (hopefully) favorable data, it might be able to time its share issuance with the bump in its stock price gained from publishing the good news so as to soften the impact to shareholders.